Holding Foreign Companies Accountable Act

Bragar Eagel & Squire, P.C. Is Investigating Zai Lab, Bowlero, and Chegg and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, August 7, 2023
P.C, CHGG, ChatGPT, NSCLC, Holding Foreign Companies Accountable Act, Patient, Holding, News, NYSE, Cryptocurrency, Audit, Pharmaceutical industry, Bowlero Corporation, Chegg

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Zai Lab and the other companies named in the SEC notification have until March 29, 2022 to challenge the charges against them.
  • On this news, Zai Lab's stock price fell $6.74 per share, or 18%, to close at $30.02 per share on March 10, 2022.
  • Then, on May 1, 2023, Chegg held a conference call to discuss its results for the first quarter of 2023.

MultiMetaVerse Holdings Limited Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

Retrieved on: 
Thursday, August 3, 2023
Letter, Failure, Face, Calendar, The Company, Animation, Holding Foreign Companies Accountable Act, Dietary supplement

SHANGHAI, Aug. 3, 2023 /PRNewswire/ -- MultiMetaVerse Holdings Limited (the "Company"), an animation and entertainment company for young consumers in China, announced today that it has received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") dated July 26, 2023, notifying the Company that it is not in compliance with the minimum market value of publicly held shares ("MVPHS") requirement set forth in Nasdaq Listing Rules for continued listing on the Nasdaq Global Market.

Key Points: 
  • SHANGHAI, Aug. 3, 2023 /PRNewswire/ -- MultiMetaVerse Holdings Limited (the "Company"), an animation and entertainment company for young consumers in China, announced today that it has received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") dated July 26, 2023, notifying the Company that it is not in compliance with the minimum market value of publicly held shares ("MVPHS") requirement set forth in Nasdaq Listing Rules for continued listing on the Nasdaq Global Market.
  • Nasdaq Listing Rule 5550(b)(2) requires companies to maintain a minimum MVPHS of US$15 million and Nasdaq Listing Rule 5810(c)(3)(D) provides that the failure to meet the minimum MVPHS requirement exists if the deficiency continues for a period of 30 consecutive business days.
  • The Notification Letter does not impact the Company's listing on the Nasdaq Global Market at this time.
  • In accordance with Nasdaq Listing Rule 5810(c)(3)(D), the Company is provided 180 calendar days, or until January 22, 2024, to regain compliance with Nasdaq Listing Rule 5550(b)(2).

Tarena Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares

Retrieved on: 
Saturday, July 29, 2023
STEAM, Calendar, Ostrinotes tarena, Holding Foreign Companies Accountable Act, Cryptocurrency, Financial adviser

Pursuant to the Nasdaq Listing Rules, the applicable grace period to regain compliance is 180 calendar days, or until January 24, 2024.

Key Points: 
  • Pursuant to the Nasdaq Listing Rules, the applicable grace period to regain compliance is 180 calendar days, or until January 24, 2024.
  • The Company can cure this deficiency if its MVPHS closes at US$15,000,000 or more for a minimum of ten consecutive business days during the compliance period.
  • The Company's management is looking into various options available to regain compliance and maintain its continued listing on The Nasdaq Global Select Market.
  • Alternatively, the Company may apply to transfer the Company's securities to The Nasdaq Capital Market, subject to the Nasdaq Capital Market's continued listing requirements.

Bragar Eagel & Squire, P.C. Is Investigating Xponential, Franchise Group, Zai Lab, and Alvotech and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 27, 2023
P.C, Franchise Group, Adalimumab, FRG, NSCLC, Holding Foreign Companies Accountable Act, Geisler, Patient, Holding, CRL, Research, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, House, News, NYSE, BLA, Food, Cryptocurrency, Audit

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Xponential purports to be the largest global franchisor of boutique fitness brands and went public on July 21, 2021 at $12.00 per share.
  • On April 6, 2022, an entity affiliated with Xponential's Chairman of the Board sold 5.175M shares at $20.00 per share in a secondary offering.
  • Zai Lab and the other companies named in the SEC notification have until March 29, 2022 to challenge the charges against them.

Bragar Eagel & Squire, P.C. Is Investigating Xponential, Franchise Group, Zai Lab, and Alvotech and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, July 22, 2023
P.C, Franchise Group, Adalimumab, FRG, NSCLC, Holding Foreign Companies Accountable Act, Geisler, Patient, Holding, CRL, Research, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, House, News, NYSE, BLA, Food, Cryptocurrency, Audit

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Xponential purports to be the largest global franchisor of boutique fitness brands and went public on July 21, 2021 at $12.00 per share.
  • On April 6, 2022, an entity affiliated with Xponential's Chairman of the Board sold 5.175M shares at $20.00 per share in a secondary offering.
  • Zai Lab and the other companies named in the SEC notification have until March 29, 2022 to challenge the charges against them.

Bragar Eagel & Squire, P.C. Is Investigating Xponential, Franchise Group, Zai Lab, and Alvotech and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, July 17, 2023
P.C, Franchise Group, Adalimumab, FRG, NSCLC, Holding Foreign Companies Accountable Act, Geisler, Patient, Holding, CRL, Research, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, House, News, NYSE, BLA, Food, Cryptocurrency, Audit

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Xponential purports to be the largest global franchisor of boutique fitness brands and went public on July 21, 2021 at $12.00 per share.
  • On April 6, 2022, an entity affiliated with Xponential's Chairman of the Board sold 5.175M shares at $20.00 per share in a secondary offering.
  • Zai Lab and the other companies named in the SEC notification have until March 29, 2022 to challenge the charges against them.

Bragar Eagel & Squire, P.C. Is Investigating Xponential, Franchise Group, Zai Lab, and Alvotech and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, July 11, 2023
P.C, Franchise Group, Adalimumab, FRG, NSCLC, Holding Foreign Companies Accountable Act, Geisler, Patient, Holding, CRL, Research, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, House, News, NYSE, BLA, Food, Cryptocurrency, Audit

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Xponential purports to be the largest global franchisor of boutique fitness brands and went public on July 21, 2021 at $12.00 per share.
  • On April 6, 2022, an entity affiliated with Xponential's Chairman of the Board sold 5.175M shares at $20.00 per share in a secondary offering.
  • Zai Lab and the other companies named in the SEC notification have until March 29, 2022 to challenge the charges against them.

Bragar Eagel & Squire, P.C. Is Investigating Xponential, Franchise Group, Zai Lab, and Alvotech and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 6, 2023
P.C, Franchise Group, Adalimumab, NSCLC, Holding Foreign Companies Accountable Act, Geisler, Patient, Holding, CRL, Research, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, House, News, NYSE, BLA, Food, Cryptocurrency, Audit

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Xponential purports to be the largest global franchisor of boutique fitness brands and went public on July 21, 2021 at $12.00 per share.
  • On April 6, 2022, an entity affiliated with Xponential's Chairman of the Board sold 5.175M shares at $20.00 per share in a secondary offering.
  • Zai Lab and the other companies named in the SEC notification have until March 29, 2022 to challenge the charges against them.

Bragar Eagel & Squire, P.C. Is Investigating Xponential, Franchise Group, Zai Lab, and Hayward and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, July 1, 2023
P.C, Franchise Group, FRG, NSCLC, NYSE, Holding Foreign Companies Accountable Act, Geisler, Patient, Holding, Research, House, News, Cryptocurrency, Audit, Hayward

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Xponential purports to be the largest global franchisor of boutique fitness brands and went public on July 21, 2021 at $12.00 per share.
  • On April 6, 2022, an entity affiliated with Xponential's Chairman of the Board sold 5.175M shares at $20.00 per share in a secondary offering.
  • Hayward Holdings further disclosed that it was reducing its 2022 guidance to reflect this inventory reduction.

Bragar Eagel & Squire, P.C. Is Investigating Zai Lab, Hayward, Ascendis, and Alvotech and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, June 26, 2023
P.C, ADR, New Drug Application, Adalimumab, NDA, Hypoparathyroidism, NSCLC, Electric Bond and Share Company v. Securities and Exchange Commission, NYSE, Holding Foreign Companies Accountable Act, Patient, Northern Transcon, Holding, CRL, FDA, Letter, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, BLA, News, Food, Cryptocurrency, Audit

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Zai Lab and the other companies named in the SEC notification have until March 29, 2022 to challenge the charges against them.
  • On this news, Zai Lab's stock price fell $6.74 per share, or 18%, to close at $30.02 per share on March 10, 2022.
  • On this news, Zai Lab's stock fell $4.88 per share, or 14.55%, on unusually high trading volume, to close at $28.66 per share on June 7, 2023.